Skip to content

Exercise Study for Breast Cancer Survivors

Enhancing Muscle Strength and Immunity in Breast Cancer

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04208074
Enrollment
30
Registered
2019-12-23
Start date
2019-11-25
Completion date
2020-12-31
Last updated
2020-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Exercise, Resistance Exercise, T cells, Immune system

Brief summary

This study evaluates the link between muscle health and immune health in breast cancer survivors. Regular exercise is known to improve overall survival in cancer patients but the mechanism is not known. In this study the investigators will evaluate if improving muscle mass and strength via exercise improves the immune system's ability to fight cancer. This is a one armed study where in 30 breast cancer survivors will be recruited to a 4 month exercise intervention. Increase in muscle mass and strength will be correlated with immune cell frequency and function.

Detailed description

Breast cancer survivors with stronger and larger muscles have better overall survival and lower recurrence than women with weaker and smaller muscles. However, the mechanism for this association is currently unknown. A recent study from the investigators has shown that there is an association between the frequency of immune cell types that kill cancer and higher muscle mass and strength, with higher muscle mass and strength correlating with a higher frequency of cancer killing, effector memory, T cells. The investigators thus propose that increasing muscle mass and strength can improve overall survival and reduce recurrence by increasing the number of cancer killing immune T cells. To test this hypothesis, the investigators will recruit 30 breast cancer survivors to an exercise program designed to increase their muscle mass and strength. The program will be optimized to each participant's level of fitness and strength and will be designed by experts in the field. Personal trainers will teach the participants how to exercise and use muscle resistance training equipment using the correct technique and will monitor progress to avoid injuries and to maximize training benefits. The investigators will collect blood (to study immune cell subsets) and measure muscle strength and body composition (to measure muscle mass) for participants before and after the study. The duration of the exercise training protocol is 4 months and participants will be asked to exercise 4 days a week; 2 days at the gym and 2 days at home.

Interventions

OTHERExercise Intervention

Participants will exercise under the supervision of expert personal trainers and follow an optimized exercise program tailored to the strength and fitness level of each participant. Participants will exercise for 16 weeks; 2 days a week at the gym for an hour and 2 days of the week at home for 45 minutes.

Sponsors

California Breast Cancer Research Program
CollaboratorOTHER
Arizona State University
CollaboratorOTHER
Tri-City Wellness & Fitness Center
CollaboratorUNKNOWN
We Support U
CollaboratorUNKNOWN
San Diego Biomedical Research Institute
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Women * Post menopausal * Stage I - III breast cancer * Breast cancer the only cancer * Can exercise for 16 weeks; 2 days a week at the gym and 2 days of the week at home * Live in the San Diego area

Exclusion criteria

* Exercise regularly in the gym. * Are on chemotherapy or radiation therapy or have been in the past month * Will be on chemotherapy or radiation therapy in the next 6 months * Have a condition that will prevent them from exercising in the gym

Design outcomes

Primary

MeasureTime frameDescription
Change in levels of factors called microRNAs in the blood16 weeks of muscle resistance trainingThe investigators will measure levels of microRNAs in the blood before and after the 16 week training protocol. The microRNAs will be detected and levels measured using a technique called qPCR.
Change in lower body strength16 weeks of muscle resistance trainingThe Knee Extension Test will be used as a measure of lower body strength. It will be performed before and after the 16 week training program using specialized exercise equipment in the gym. This test will measure the maximum weight that be lifted by the legs and will be measured in kilograms.
Change in levels of inflammatory factors in the blood16 weeks of muscle resistance trainingThe investigators will measure the levels of inflammatory and anti-inflammatory factors, called cytokines, in blood collected before and after the 16 week training program. Cytokines will be measured in picograms per milliliter.
Change in frequency of effector memory immune cells16 weeks of muscle resistance trainingEffector memory cells are immune cells that can kill cancer. We will measure the frequency of these cells before and after the 16 week training program to see if they increase. Flow Cytometry techniques will be used to determine the frequency of these cells.
Change in frequency of central memory immune cells16 weeks of muscle resistance trainingCentral memory cells are immune cells that are linked to poor prognosis in patients with cancer. We will measure the frequency of these cells before and after the 16 week training program to see if they decrease. Flow Cytometry techniques will be used to determine the frequency of these cells.
Change in frequency of regulatory immune cells16 weeks of muscle resistance trainingRegulatory immune cells, also called Tregs, are a type of immune cell that keeps the immune system from becoming over active. However, people with too many Treg cells might be more susceptible to cancer growth. We will measure the frequency of Tregs by Flow Cytometry before and after the 16 week training program to see if exercise reduces their frequency.
Change muscle mass16 weeks of muscle resistance trainingDual energy x-ray absorptiometry (DEXA) scans will be used to measure the appendicular muscle mass (amount of muscle in the arms and legs) before and after the 16 week training program. The appendicular muscle mass index is calculated using the appendicular muscle mass divided by height square and is measured in kg/m\^2.
Change in hand grip strength16 weeks of muscle resistance trainingThe level of hand grip strength is a good indicator of body strength. Hand grip strength will be measured in kilograms using an instrument called a dynamometer before and after the 16 week training program.
Change in capacity to climb stairs16 weeks of muscle resistance trainingThe stair climb test measures the amount of power used by a participant to climb a set of stairs. Power is measured in Watts (W) and is calculated using the time taken to climb the stairs (seconds), the vertical height of the stairs (meters) and the weight (kilograms) of the participant and is a standard measure of performance. The stair climb test will be performed before and after the 16 week training program.
Change in upper body strength16 weeks of muscle resistance trainingThe Chest Press Test will be used to measure upper body strength. It will be performed before and after the 16 week training program using specialized exercise equipment in the gym. This test will measure the maximum weight that be lifted by the arms and will be measured in kilograms.

Secondary

MeasureTime frameDescription
Physical activity1 day before, and 1 day after the 16 week muscle resistance training programPhysical activity will be determined using the Framingham Physical activity questionnaire. Overall physical activity will be calculated using the physical index score, with a higher score indicating higher physical activity.
Body Mass Index1 day before, and 1 day after the 16 week muscle resistance training programBMI will be calculated using height and weight measurements and reported as kg/m2

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026